Ann: ATL1102 for MS and DMD Update, page-26

ITs not serious.Runs are on the board.AEI did serious DD on ANP..They came on board for DMD..
To get a bonus with an IND for RRMS and SPMS a market worth $20 billion.
Do you know how difficult it is to get a INd approved by the FDA.especially with a New Drug in Antisense and a journey to the primary target through the CNS..?
KP your own words "This company is on its knees and with nobody wanting to license out its unproven compounds, its in a very dire situation ."
Now...that the FDA has approved the IND it will generate more PHARMA interest.No one thought it was possible except the ANP board.